Shenzhen Chipscreen Biosciences Co. Ltd. Class A · SSE:688321

Shenzhen Chipscreen Biosciences Co. Ltd. Class A financial statements

Shenzhen Chipscreen Biosciences Co. Ltd. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue909.5M657.9M523.7M529.9M430.4M269.5M173.8M147.7M110.5M85.4M
Cost of revenue117.2M87.5M57.0M30.0M21.6M13.5M7.29M5.51M5.33M2.17M
Gross profit909.5M570.5M466.7M499.9M408.9M256.0M166.5M142.2M105.2M83.2M
Research and development221.6M214.5M270.4M163.7M130.0M92.3M51.4M43.2M37.6M32.4M
Selling, general and administrative262.3M77.3M80.0M71.2M75.0M45.2M32.3M27.3M19.2M21.6M
Operating income50.9M-178.5M97.1M16.0M22.3M37.0M21.7M32.6M24.5M2.03M
Depreciation and amortization70.0M59.0M45.6M38.7M19.6M11.1M4.81M4.34M4.38M3.71M
EBITDA120.9M-119.5M142.7M54.7M41.9M48.1M26.5M37.0M28.9M5.74M
Interest expense35.7M34.2M34.9M20.3M4.86M1.06M1.54M573.3K02.43M
Income before tax50.8M-96.7M97.0M15.2M18.6M36.2M20.7M32.2M23.7M5.24M
Income tax-232.4K17.9M47.8M2.34M-3.36M5.12M1.31M1.00M-416.5K
Net income51.1M-114.6M88.8M17.5M22.0M31.0M19.4M31.2M24.1M5.24M
Earnings per share, basic0.13-0.280.220.040.050.080.050.090.070.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents347.6M375.2M375.4M508.6M300.2M318.7M376.1M131.3M102.5M108.6M
Short-term investments295.3M94.1M216.7M291.1M82.1M261.9M4.02M41.8M167.9M101.5M
Receivables287.0M178.4M221.5M154.8M122.9M41.5M81.3M50.4M30.2M-104.2M
Inventory57.7M40.8M47.1M28.5M15.4M12.4M11.0M8.45M9.17M3.84M
Current assets1.18B1.08B1.13B1.18B638.8M769.1M1.07B233.5M310.8M226.0M
Property, plant and equipment699.0M586.3M380.0M281.5M183.1M47.2M
Total assets3.65B3.25B3.20B2.90B1.89B1.73B1.69B716.3M656.0M403.1M
Accounts payable3.78M2.19M9.03M323.5K2.23M3.54M221.9K69.2K3.94M80.6K
Current liabilities843.9M451.3M390.8M540.5M293.8M146.9M137.3M81.5M76.7M111.6M
Long-term debt1.04B1.09B899.2M598.0M4.88M22.8M36.9M87.5M65.0M30.0M
Total debt1.20B1.04B810.1M151.5M60.0M104.8M87.5M75.0M30.0M
Total liabilities-1.66B1.67B1.49B1.32B476.8M232.4M245.1M239.4M205.5M189.7M
Shareholders' equity1.66B1.58B1.59B1.52B1.42B1.49B1.45B476.9M450.6M213.4M
Shares outstanding408.0M408.0M408.3M406.6M409.7M410.1M376.4M359.9M348.7M330.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations97.0M76.1M-143.2M43.3M124.8M93.6M-24.6M22.8M2.73M59.8M
Capital spending-178.6M-268.5M-229.0M-400.2M-288.5M-336.3M-133.0M-140.7M-132.8M-65.8M
Free cash flow-81.6M-192.4M-386.3M-356.9M-163.7M-242.6M-157.6M-118.0M-130.1M-6.04M
Cash from investing-296.0M-389.1M-801.7M-30.6M-108.7M-721.5M-13.3M-196.1M-135.6M
Cash from financing175.4M382.6M861.3M-63.3M-45.4M950.2M18.0M192.2M141.6M
Dividends paid-31.7M-27.6M-18.7M-12.2M-4.22M-3.28M-1.48M-549.9K-2.32M-3.49M
Share buybacks-15.0M-3.80M-155.5M
Change in cash-222.5M-44.1M-148.6M115.1M28.6M-64.5M204.8M28.8M-3.43M68.1M